Combination of beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders

Details for Australian Patent Application No. 2003260279 (hide)

Owner Astion Development A/S

Inventors Weidner, Morten Sloth

Agent FB Rice

Pub. Number AU-B-2003260279

PCT Number PCT/DK03/00263

PCT Pub. Number WO2003/097073

Priority PA 2002 00586 19.04.02 DK; 60/373,615 19.04.02 US

Filing date 22 April 2003

Wipo publication date 2 December 2003

Acceptance publication date 24 January 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/235 (2006.01)

A61K 31/325 (2006.01) - Carbamic acids

A61K 31/36 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4458 (2006.01) - only substituted in position 2, e.g. methylphenidate

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/522 (2006.01)

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/7016 (2006.01) - Disaccharides, e.g. lactose, lactulose

A61K 31/702 (2006.01) - Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

A61K 31/726 (2006.01) - Glycosaminoglycans, i.e. mucopolysaccharides

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): PA 2002 00586 19.04.02 DK; 60/373,615 19.04.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003260279

24 January 2008 Application Accepted

  Published as AU-B-2003260279

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003260280-COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES RESPONSIVE TO ANTIANGIOGENETIC THERAPY

2003260278-Pharmaceutical formulation with nonsteroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells